This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) shed 2.97% to $55.57 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&amp;P 500 Index rising 0.30% to 7,405.73 and the Dow Jones Industrial Average falling 0.16% to 50,786.01.
The stock's fall snapped a three-day winning streak.
Bristol Myers Squibb Co. closed 11.63% short of its 52-week high of $62.89, which the company achieved on March 2nd.
The stock underperformed when compared to some of its competitors Monday, as Johnson &amp; Johnson (JNJ) fell 0.26% to $232.16, Pfizer Inc. (PFE) fell 1.61% to $25.62, and Abbott Laboratories (ABT) fell 0.63% to $90.50.
Trading volume (11.9 M) eclipsed its 50-day average volume of 10.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 8, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-08-26 1637ET

Bristol Myers Squibb (BMY) shares fell 2.97% to $55.57 on Monday, underperforming competitors like Johnson & Johnson, Pfizer, and Abbott Laboratories. The decline ended a three-day winning streak, with the stock trading 11.63% below its 52-week high of $62.89. Trading volume reached 11.9 million, exceeding the 50-day average.

MarketWatch Automated

Bristol Myers Squibb

S&P 500

Dow Jones Industrial Average

Johnson & Johnson

Pfizer

Abbott Laboratories

Factset Research

Bristol-Myers Squibb Company

Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors